Fact CheckerSign in

NCT07177599Completed

Pancreatic Disease Burden in Older Adults (1990-2040)

Global, Regional, and National Burdens of Pancreatic Cancer and Pancreatitis Among Older Adults From 1990 to 2021 With Projections to 2040: A Comprehensive and Comparative Investigation

Source: ClinicalTrials.gov · Last updated 17 Sept 2025

Brief summary (registry, in English)

Using data from the Global Burden of Disease Study 2021, the investigators analyzed age-standardized incidence, mortality, and disability-adjusted life-years (DALYs) for pancreatic cancer and pancreatitis in adults aged ≥70 years across 204 countries and territories, stratified by sex, Socio-Demographic Index (SDI), health system performance, and region. The investigators calculated estimated annual percentage changes (EAPCs), applied age-period-cohort modelling, and used Bayesian models to project future burden. Attributable burdens for key risk factors were also estimated.

Status (registry)
Completed
Study type
Observational
Enrollment
723415 (actual)
First submitted
10 Sept 2025
Start date
1 Jan 1990
Primary completion date
31 Dec 2021
Lead sponsor
Changhai Hospital
NCT number
NCT07177599

What you commit to

  • Study type: Observational
  • Participants enrolled: 723415
  • From 1 Jan 1990 to the primary completion date, 31 Dec 2021
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Other non-pancreatic diseases

Age

  • Age \<70 years

Who the study is looking for

  • Diagnosis with pancreatic cancer or pancreatitis
  • Diagnosis in 1990 through 2021
  • Age 70+ years

Age in the registry: 70 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.